Lannett Company, Inc. is recalling approximately 683,149 bottles of Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL. This prescription medication is used to treat acid reflux and ulcers but was found to contain an impurity called N-Nitrosodimethylamine (NDMA). NDMA is classified as a probable human carcinogen, meaning it could increase the risk of cancer with long-term exposure. Consumers who have this medication should consult their healthcare provider or pharmacist immediately to discuss alternative treatments.
The product contains NDMA, a substance that is classified as a probable human carcinogen based on laboratory tests. While NDMA can be found in water and foods, the levels detected in these specific batches of medication exceed acceptable safety limits set by health authorities.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.